Edilma Paraguai de Souza Selected Research

Fluorometholone (FML)

2/2005	Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
6/2004	Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.
12/2003	Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine.
6/2003	IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edilma Paraguai de Souza Research Topics

Disease

5	Visceral Leishmaniasis (Kala Azar) 02/2005 - 04/2002
3	Infections 02/2005 - 06/2003
1	Leishmaniasis 02/2005
1	Cutaneous Leishmaniasis 02/2005
1	Hypersensitivity (Allergy) 12/2003
1	Ganglion Cysts (Ganglion) 12/2003

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 02/2005 - 06/2003
4	Fluorometholone (FML)FDA Link 02/2005 - 06/2003
3	fucose-binding lectinIBA 02/2005 - 12/2003
2	N-Glycosyl HydrolasesIBA 02/2005 - 04/2002
2	Immunoglobulin G (IgG)IBA 02/2005 - 06/2003
2	AntigensIBA 12/2003 - 04/2002
1	DNA VaccinesIBA 02/2005
1	SaponinsIBA 12/2003
1	CytokinesIBA 12/2003

Therapy/Procedure

2	Immunotherapy 06/2004 - 12/2003
1	Therapeutics 12/2003